跳至主要内容
临床试验/NCT01249963
NCT01249963Unknown不适用

Evaluation of Oral Enteral Nutrition Supplement in Patients With Mild Acute Pancreatitis

Vegenat, S.A.2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
2
主要终点
Acceptance, Tolerance and Nutritional Status

研究概览

简要总结

The aim of the study is to evaluate the beneficial effects of the administration of enteral nutrition product with milk proteins, monounsaturated fatty acids and low dextrose equivalent maltodextrin and enriched in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and medium chain triglycerides (MCT) in patients with mild acute pancreatitis. All this against other specific product.

The main objectives of this project are:

  • Comparing the tolerance of both preparations.
  • Comparing the evolution of nutritional status in both groups.
  • Comparing the evolution of inflammatory parameters in both groups

详细描述

Oral administration of an oligomeric formula with milk proteins, mainly whey protein partially hydrolysate, monounsaturated fatty acids (AGM) and low dextrose equivalent maltodextrin and enriched in polyunsaturated fatty acids (PUFA) of omega-3 series, EPA and DHA, and MCT designed for nutritional support of patients with compromised intestinal function, to maintain or improve nutritional status and reduce the inflammatory response in undernourished patients with mild acute pancreatitis, compared with oligomeric enteral nutrition product, low in fat and rich in glutamine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 with Mild Acute Pancreatitis.

排除标准

  • Patients with Several Acute Pancreatitis
  • Patients with life expectancy less than 48 hours.
  • Renal (creatinin > 2,5 mg/dl) or kidney failure (GOT/GPT>2 from laboratory normal value)
  • Patients with diabetes mellitus prior to acute pancreatitis.
  • To take part in another study.
  • Pregnant patients
  • Informed consent absence.

结局指标

主要结局

Acceptance, Tolerance and Nutritional Status

时间窗: 1 year

* To compare the acceptance and tolerance of both products. * To compare the nutritional status in both arms.

次要结局

  • Inflammatory parameters evolution and EN complications(1 year)

研究者

发起方
Vegenat, S.A.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Enteral Nutrition Product in Mild Acute Pancreatitis | 临床试验